Introduction peptic ulcer disease is major diseases of the gastrointestinal tract seen throughout the world 1 . The formation of peptic ulcer diseases depends on the presence of acid and peptic activity in gastric juice with a breakdown in mucosal defenses of the gastrointestinal tract 2 . The prevalence of Helicobacter pylori infection and widespread use of acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs (NSAIDs) are known etiologic agents disrupting mucosal resistance to injury 3,4 . Several other pathogenic elements postulated for gastrointestinal lesions, include prostaglandins deficiency, bile acids, bacterial flora, and nitric oxide 5,6 , yet the precise mechanisms remain unknown. Currently, the prevention and cure of peptic ulcer diseases are among global health challenges confronting medicine 2 . In our review, most reported studies give the general idea of peptic ulcer and its management using synthetic drugs demonstrated intermittent relapses and adverse drug interactions 7,8,9 . However, many medicinal plants have been reported to possess beneficial effects in gastrointestinal disorders, especially ulcerative peptic diseases with a high level of safety compared to most synthetic drugs 10 . In developing countries, most people still rely on medicinal plants to meet their health needs, especially in cases where synthetic medicines could not provide relief from hard-to-cure illnesses 11,12 . Cadaba farinosa belongs to the capparidaceae (capparaceae) family 13 . The plant is enriched with abundant phytochemicals, including flavonoids and alkaloids are widely used in traditional medicine as antibacterial, antiprotozoal and anthelminthic agents to treats diarrheal, dysentery, and gastrointestinal parasites 13,14 . The stem bark of Cadaba farinosa served as aperients, purgative, and stomachic stimulants. In that desert of India and Pakistan, its extract is externally applied to fresh wounds to prevent sepsis, thereby assisting in healing 15,16 . In Nigeria, the analgesic and anti-inflammatory properties of Cadaba farinosa was reported among the people of Maiduguri, Jimeta, and Nguru 17 .The plant was also used in the management of gastric and duodenal ulcers by inhibition of carbonic anhydrase 18 .Hence, these findings prompted us to study the possible histological effects of the aqueous stem bark extract on the gastrointestinal tract. # II. # Materials and Method a) Experimental Animals Wistar rats were procured from the Animal House, Faculty of Pharmaceutical Science, Usmanu Danfodiyo University Sokoto, and maintained with free access to standard animal pellets and water. The permission and approval for animal studies with Reg. NO: PTAC/Cf/OT/004-18 was obtained from the Faculty of Pharmaceutical Sciences, Animal Ethics Committee, Usmanu Danfodiyo University Sokoto. # b) Plant Collection The fresh stem bark of Cadaba farinosa was harvested from its natural habitat at the Faculty of Pharmaceutical Science, Usmanu Danfodiyo University Sokoto. The plant was authenticated and deposited at the Department of Pharmacognosy and Ethno medicine, Usmanu Danfodiyo University Sokoto, Nigeria. # c) Plant Extraction The fresh inner stems bark was shadow dried and pounded into small pieces using pestle and mortar. About 210g powdered plant material was soaked and extracted in 600mL of water at room temperature for 24 hours 19 . The liquid filtrates were concentrated and evaporated to dryness at 45°C in a water bath. The aqueous extract was stored at -4°C until used. # d) Experimental Design The acute toxicity and LD 50 determination were carried out using Lorke's method 20 . According to guideline 423 of the Organization for Economic Cooperation and Development (OECD), the first phase consists of nine Wistar rats that were separated into three groups of three rats each and the aqueous extract was administered by gavage at dose levels 10, 100, and 1000 mg/kg/day. A cage side observation was done to detect any behavioral signs of toxicity salivation, erection of the hair, diarrhoea or mortality. Following the absence of toxicity sign, the second phase according to Lorke's consisted of three rats that were administered with dose levels 1600, 2900, and 5000mg/kg/24 hours. The animals were observed for signs of toxicity. In the sub-acute study, thirty (30) male and female Wistar rats were selected and randomized into five groups of six rats per group. Group 1 served as the control while the rats in groups 2, 3, and 4 were administered with plant extract by gavage at dose levels 100, 200, 300, and 400mg/kg for twenty-eight days. # e) Tissue Histology The intestines of Wistar rats were excised by abdominal incision and the tissues were fixed in 10% formal saline for 24 hours before being processed and embedded in paraffin wax. The tissues were sectioned with a rotary microtome at 5µm, and the cut sections were stained with Haematoxylin and Eosin (H&E) stain 21 . The stained slides were carefully examined under a light microscope at high power magnification, and photomicrographs were taken 22 . # III. # Results # a) Acute toxicity and LD 50 determination The toxicity study and LD 50 determination result (Table 2) showed that oral administration of the aqueous stem bark extract of Cadaba farinosa at dose levels 10, 100, 1000mg/kg/24hours produced no behavioral sign of toxicity or mortality. In Phase II, oral administration of the extract at dose levels 1600, 2900, and 5000mg/kg/day, indicated neither behavioral change nor death. The animals were as active as control. Therefore, the median lethal dose (LD 50 ) of aqueous stem bark extract of Cadaba farinosa is above 5000mg/kg. IV. # Discussion Gastrointestinal lesions (ulcerative peptic diseases) is associated with several pathogenic elements, including prostaglandins deficiency, bile acids, bacterial flora, and nitric oxide, 5,6 yet the precise mechanisms remain unknown 23 . However, the overwhelming proportions of chemical agents (84.45%) used in most pharmaceutical industries for the production of conventional drugs used for the management of gastrointestinal lesions are gotten from plants 24 . In the present study, the acute toxicity study revealed that oral administration of Cadaba farinosa extract up to 5000mg/kg produced no immediate signs of toxicity or mortality indicating that the LD 50 was above 5000 mg/kg, therefore, this explains that aqueous extract of Cadaba farinosa could be administered to animals with some degree of safety, through oral route where absorption might not be complete due to inherent factors limiting gastrointestinal tract absorption 25 . Our histological finding, showed a mucosa layer with few intestinal goblet cells lined by epithelial cells with intact submucosa and smooth muscle layers (Plate 1), while extract dose level 100mg/kg/28days showed considerably increased intestinal goblet cells and well-preserved submucosa and smooth muscle layers (Plate 2). A mucosa layer with numerous intestinal goblet cells that was lined by epithelial cells and wellpreserved submucosa, and smooth muscle layers were seen in animals at dose levels 200, 300, and 400mg/kg compared to the normal control with few intestinal goblet cells. Intestinal goblet cells are unicellular glands 26 . These cells synthesized and secretes mucin and cyclooxygenase (COX) responsible for the synthesis of prostaglandin that is expressed in cyclooxygenase pathway 1 (COX-1) and the inducible cyclooxygenase pathway 2 (COX-2) isoforms 27 . The intestinal goblet cells following oral administration of aqueous stem bark of Cadaba farinosa is indicative of high secretion of mucin COX-2 that would preserve vulnerable cellular compartment of the gastrointestinal tract. The luminal prostaglandin modulates acid concentration by inhibiting acid secretion, alter blood flow, and stimulate mucus and bicarbonate secretion leading to dramatic protection against mucosal damage. Our result is similar to the role of endogenous prostaglandins in gastric secretion and mucosa defence 28 , the anti-inflammatory effects of prostaglandins in ameliorating mucosal damage 26,27 , and stimulation of duodenal bicarbonate and mucus secretion mediated intestinal mucosal protection 29,30,31 . These physiological functions of mucin COX-2 could modulate major etiologic factors implicated in ulcerative peptic diseases, including lesions caused by NSAIDs were effectively prevented by supplementation of exogenous prostaglandinendoperoxide synthase (PGE2) 31,32,33 . Therefore, stem bark extract of Cadaba farinosa is a possible source of a drug, which modulates secretions of mucus, acid, and bicarbonates preceding dramatic protection against mucosal damage risk factors of ulcerative peptic diseases and gastrointestinal hemorrhage. V. # Conclusion This study showed that acute oral administration of aqueous stem bark extract of Cadaba farinosa forsk is safe up to 5000mg/kg body weight/day. Sub-chronic oral administration of aqueous stem bark extract of Cadaba farinosa forsk at the tested doses showed numerous intestinal goblet cells that secretes mucin and cyclooxygenase (COX) responsible for the synthesis of prostaglandin. Hence, Cadaba farinosa forsk is a possible source of anti-peptic ulcer drug since prostaglandins plays a critical role in the background of gastrointestinal lesions. ![Extract administration of 200,300 and 400mg/kg/28 days showed numerous intestinal goblet cells, and well-preserved submucosa and smooth muscle layers (Plate 3, 4, and 5).](image-2.png "") 12![Normal control showed a mucosa layer with few intestinal goblet cells lined by epithelial cells and intact submucosa and smooth muscle layers. (H&E. X100). Administration of 100mg/kg/28days showed a mucosa layer with considerably increased intestinal goblet cells lined by epithelial cell and well-preserved submucosa and smooth muscle layers. (H&E. X100).](image-3.png "Plate 1 :Plate 2 :") 5![Administration of 400mg/kg/28days showed a mucosa layer with numerous intestinal goblet cells lined by epithelial cells, and well-preserved submucosa and smooth muscle layers H&E. X100).](image-4.png "Plate 5 :") ![](image-5.png "") ![](image-6.png "") 1DoseMortalitymg/kg body weightPhase IPhase II10-100-1000-1600-2900-5000- 2DoseMortalitymg/kg body weightPhase IPhase II100/3-1000/3-10000/3-1600-0/12900-0/15000-0/1b) Tissue effects of plant extractOur histological finding showed normalintestinal goblet cells lined by epithelial cells and intactsubmucosa and smooth muscle layers (Plate 1).Extract administration of 100mg/kg/28daysshowed considerably increased intestinal goblet cellslined by epithelial cells and well-preserved submucosaand smooth muscle layers (Plate 2). ## Acknowledgements We acknowledge the effort of Ayooye Samuel, the Principal Medical Laboratory Scientist of the Department of Histopathology, Usmanu Danfodiyo University Teaching Hospital Sokoto, Nigeria, for taking good photomicrographs for this study. ## Funding ## No funding sources ## Conflict of interest None declared ## Ethical approval No: PTAC/Cf/OT/004-18 was obtained from the Faculty of Pharmaceutical Sciences, Animal Ethics Committee, Usmanu Danfodiyo University Sokoto. * Peptic Ulcer Disease: A brief review of conventional therapy and herbal treatment options LucijaKuna JelenaJakab RobertSmolic NikolaRaguz-Lucic AleksandarVcev MartinaSmolic Journal of Clinical Medicine 8 179 2019 * Indian Medicinal Plants for Treatment of Ulcer: Systematic Review SPahadiya Anitakumari Rambhai Sisodia UK Journal of Pharmaceutical and Biosciences 6 6 2018 * Peptic ulcer disease: descriptive epidemiology, risk factors, management and prevention. www.smgebooks. com, Creative Commons Attribution 4.0 International License AejazHabeeb KSantosh AvinashTiwari ShaswathiBardia SandeepKhan SafwaanKumar Vishwakarma Aleem AhmedHabeeb Khan * Peptic ulcer disease. Management of digestive disorders MonjurAhmed * Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation BKReuter NMDavies JLWallace Gastroenterology 112 1997 * NSAID-induced small intestinal damage: roles of various pathogenic factors KTakeuchi HSatoh Digestion 91 2015 * Identification of medicinal plants of Urmia for treatment of gastrointestinal disorders MahmoudBahmania ArmanZargaranb MahmoudRafieian-Kopae Revista Brasileira Farmacognosia 24 2014 * D: Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland JYKang AElders AMajeed MaxwellJ DBardhan K Aliment Pharmacol Ther 24 1982-2002. 2006 * Beneficial medicinal plants in digestive system disorders (part 2): plant based review Ali Esmail Al-Snafi IOSR Journal of Pharmacy 6 7 2016 * ASTripathi VChitra DSheikh AMohale Dewan Immunomodulatory Activity of the Methanol Extract of Amorphophallus campanulatus (Araceae) Tuber. Tropical Journal of Pharmaceutical Research 9 5 2010 * Effects of aqueous leaf extracts of Sennaoccidentalis on rat kidney RTIsah MohammedM O MuhammadA T SahabiS M UmarZ U MahmudR IAbubakar U Africa Journal Biomedical Research 21 2018 * Phytopharmacological perspective of Cadaba farinosa forsk UmeshTelrandhe VaibhavUplanchiwar American Journal of Phytomedicine and Clinical Therapeutics 1 2013 * Phytochemical analysis and biological assay of the methanolic leaf extract of Cadaba farinosa Forsk (Capparidaceae) JEzekiel TKadam International Journal of Advanced Research 3 2015 * Medicinal flora of the Thar Desert: An overview of problems and their feasible solutions AHabib RBGhulam LAbdul Zones Aridas. Pakistan 2004. 2004 * Antifungal effect of leaf extract of some medicinal plants against Fusariumoxysporum causing wilt disease of SolanummelogenaL NSiva Ganesan NBanumathy Muthuchelian Tamil Nadu India 2008 * Ethno botanical survey of folkloric plants used in managing breast cancer by the traditional medical practitioners of North-East Nigeria ZMohammed ADaja HHamza AGidado IHussaini Journal of Medical and Applied Bioscience 6 2014 * In vitro inhibitory effect of methanol leaf extract of Cadabafarinosa on carbonic anhydrase activity IbrahimS I AmehD AAtawodi SEUmar IAJajere UMMohammed SY International Journal of Biochemistry Research and Review 11 4 2016 * Cabeza, I. Villegas and V. Motilva anti-oxidant mechanisms involved in gastroprotective effects of Quercetin MJMartín CLa -Casa CAlarcón-De-La-Lastra J Z. Naturforsch 52 1998 * Selective Toxicity Diterpene from Euphorbia Poi sonic OMajekodunmi KZany IOlanyaga LShi JMelanhin Journal of Medicinal Chemistry 39 1996 * A new approach to practical acute toxicity testing DLorke Archives of Toxicology 53 1983 * Histochemistry and Tissue Pathology. Principles and Techniques OGAvwioro 2014 4 th Edition * Principles and Techniques in Histology Micrograph and Photomicrography. 2 nd Edition DSingh CBS Publishers and Distributors. Newdelhi. India 2006 * Roles of prostaglandin E and EP receptors in mucosal protection and ulcer healing in the gastrointestinal tract KojiTakeuchi KikukoAmagase Arch Dig Disord 1 2 2017 * Treatment of liver and spleen illnesses by herbs: Recommendations of Avicenna's heritage "Canon of Medicine NaserMozhgan Ghobadi Pour AsgharMirazi Seif Avicenna Journal of Phytomedicine 9 2 2019 * Effects of Aqueous Stem Bark Extract of Citrusaurantifolia on the Gastrointestinal Tract of Wistar Rats PAIdakwoji JNAjima JCAnosike EBAmadi PCNweje-Anyalowu Asian Journal of Research in Medical and Pharmaceutical Sciences 5 3 2018 * Colour Text Book of Histology. Digestive system LesliePGartner JamesLHiatt 2007 Elsevier publisher 400 Small intestine. 3 rd edition * Expression of cyclooxygenase-2 in intestinal goblet cells of prediabetic NOD Mice CLuo VJ OLaine LYilnen Teros MMakinen ARistimaki OSimell Acta Physiologica Scandinavica 174 2002 * Role of endogenous prostaglandins in gastric secretion and mucosal defence MCohem Clin. Invest. Med 10 3 1987 * Smithies. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2 OMorteau SGMorham RSellon LADieleman RLangenbach Journal of Clinical Investigations 105 2000 * Role of sulphydryls in mucosal injury caused by ethanol. Relation to microvascular permeability, gastric motility and cytoprotection KTakeuchi OMegumu NHiromichi SOkabe J. Pharmacology. Exp. Ther 248 1988 * The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach HAraki HUkawa YSugawa KYagi KSuzuki KTakeuchi Aliment Pharmacol. Ther 14 1 2000 * Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats EAihara YNomura YSasaki FIse KKita KTakeuchi Life Sci 80 2007 * 16-dimetyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors TKunikata ATanaka TMiyazawa Dig Dis Sci 47 2002 * Dual action of nitric oxide in pathogenesis of indomethacininduced small intestinal ulceration in rats ATanaka TKunikata AKonaka Journal of Physiol Pharmacol 50 1999